Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study).

Saved in:

Bibliographic Details
Title:	Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study).
Authors:	Rodriguez, JM¹, Delgado, M², Viciana, P³, Lopez-Ruz, MA⁴, Leal, M³, Alcacer, F⁵, Deig, E⁶, Antela, A⁷, Pedrol, E⁸, Moreno, S¹
Source:	Journal of the International AIDS Society. Nov2010 Supplement S3, Vol. 13, pP79-P79. 2p.
Database:	Academic Search Ultimate

Description
ISSN:	17582652
DOI:	10.1186/1758-2652-13-S4-P79